Clinical Trials on Actinic Keratosis (AK)

Total 1737 results

Wright State University

Completed

Photodynamic Therapy-Induced Immune Modulation: Part III

Actinic Keratosis | Photodynamic Therapy

United States
LEO Pharma

Completed

Efficacy and Safety of Ingenol Mebutate Gel 0.06% When Applied Once Daily for 2, 3 or 4 Consecutive Days to a Treatment Area of Approximately 250 cm2 on Trunk and Extremities in Subjects With Actinic Keratosis

Actinic Keratosis

United States
Maastricht University Medical Center

Active, not recruiting

OCT and Invasion in Cutaneous Skin Lesions

Keratosis, Actinic | Actinic Keratoses | Diagnosis | Bowen's Disease | Cutaneous Squamous Cell Carcinoma

Netherlands
NAOS Institute of Life Science

Not yet recruiting

MRB 0.3% Serum Effectiveness on 2 Early Clinical Markers of Photoinduced Cutaneous Aging: Actinic Lentigo and Actinic Keratosis

Actinic Keratosis | Actinic Lentigo
LEO Pharma

Completed

Safety and Efficacy of Escalating Doses of LEO 43204 Applied Once Daily for Two Consecutive Days on Approximately 250 cm2 on Trunk and Extremities in Subjects With Actinic Keratosis

Actinic Keratosis

United States, Canada
LEO Pharma

Completed

Safety and Tolerability of Different Concentrations of an Ingenol Derivative Field Therapy in the Treatment of Actinic Keratosis

Actinic Keratosis

Australia
TORQUR

Recruiting

Study on the Safety and Efficacy of Bimiralisib Gel in Participants Suffering From Actinic Keratosis

Actinic Keratosis

Switzerland
LEO Pharma

Completed

A Simultaneous Treatment Regimen Compared to a Sequential Treatment Regimen With Ingenol Mebutate Gel 0.015% and 0.05% of Two Areas With Actinic Keratosis on Face/Scalp and Trunk/Extremities

Actinic Keratosis

Italy
Galderma R&D
Parexel

Completed

Metvix Daylight PDT in Actinic Keratosis (SESAME)

Actinic Keratosis

Spain, United Kingdom, Australia, France, Italy, Netherlands, Switzerland
Joint Authority for Päijät-Häme Social and Health...
Tampere University; Tampere University Hospital; Päijänne Tavastia Central Hospital and other collaborators

Completed

Daylight PDT for Actinic Keratoses: a Multicentre Study Comparing Two Photosensitizers (BF-200 ALA Versus MAL)

Actinic Keratosis | Natural Daylight Photodynamic Therapy

Finland
LEO Pharma

Completed

Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Balding Scalp Including 12-month Follow-up

Actinic Keratosis

United States
LEO Pharma

Completed

Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Face or Chest Including 12-month Follow-up

Actinic Keratosis

United States
DUSA Pharmaceuticals, Inc.

Completed

Controlled Study of the Occurrence of Actinic Keratosis on the Face After Cryotherapy + Aminolevulinic Acid (ALA) Photodynamic Therapy

Actinic Keratosis

United States
Frank Meyskens
National Cancer Institute (NCI)

Terminated

Green Tea Extract in Treating Patients With Actinic Keratosis

Non-melanomatous Skin Cancer

United States
DUSA Pharmaceuticals, Inc.

Completed

Microneedle Lesion Preparation Prior to Aminolevulinic Acid Photodynamic Therapy (ALA-PDT) for AK on Face

Actinic Keratosis

United States
Peplin

Completed

A Multi-center Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on the Head (Face or Scalp)

Actinic Keratosis

United States, Australia
Peplin
TKL Research, Inc.

Completed

A Long Term Follow up Study of Patients Who Have Completed the PEP005-016 or PEP005-025 Studies

Actinic Keratosis

United States, Australia
Tennessee Clinical Research Center
Graceway Pharmaceuticals, LLC

Terminated

Treatment of Actinic Keratoses of the Face With Imiquimod 3.75% Cream Followed by Photodynamic Therapy

Actinic Keratosis

United States
Icahn School of Medicine at Mount Sinai
LEO Pharma

Completed

Ingenol Mebutate 0.015% Gel in the Treatment of Actinic Keratoses (AK) on the Face and Scalp

Actinic Keratosis

United States
Bispebjerg Hospital
Galderma R&D

Completed

Laser and Microdermabrasion Before Photodynamic Therapy for Actinic Keratoses in Field-cancerized Skin

Actinic Keratosis | Sun Damaged Skin | Solar Keratosis | Solar Skin Damage
University of Sao Paulo
University of Regensburg

Completed

Photodynamic Therapy (PDT) Effect on Large Surface Photodamaged Skin (PDT)

Actinic Keratosis | Photoaging | Solar Elastosis
Skin Laser & Surgery Specialists
LEO Pharma

Completed

Clinical and Histologic Evaluation of Picato 0.15% Gel in the Cosmetic Improvement of Photoaged Skin

Actinic Keratosis | Photo-aged Skin
Medical University of Graz

Completed

Tirbanibulin 1% Ointment for the Treatment of Chronically Sun-damaged Skin on the Face (SunDamage)

Actinic Keratosis

Austria
Biofrontera Bioscience GmbH

Completed

Study to Evaluate Safety and Tolerability of BF-200 ALA (Ameluz®) for Photodynamic Therapy in the Treatment of the Expanded Field of Actinic Keratosis on Face and Scalp

Keratosis | Actinic Keratosis | Keratosis, Actinic

United States
University of California, San Francisco

Completed

Safety and Efficacy of Ingenol Mebutate Gel 0.015% for Treatment of AK on the Face in Solid Organ Transplant Recipients

Actinic Keratosis

United States
University of Dundee

Completed

Menthol for PDT Pain Relief (MentholPDT)

Actinic Keratosis

United Kingdom
Galderma R&D

Completed

Metvix PDT Versus Vehicle PDT With Aktilite CL128 Lamp in Patients With Actinic Keratosis on the Face and Scalp

Actinic Keratosis

United States
Promius Pharma, LLC

Completed

Eight Week Study of Treatment With DFD-07 for Actinic Keratosis of the Face and Scalp

Actinic Keratosis

Germany
LEO Pharma

Completed

Safety of LEO 43204 for Actinic Keratosis Applied on Face/Chest, Scalp and Trunk/Extremities, Respectively

Actinic Keratosis

United States
LEO Pharma

Completed

Safety and Efficacy of Doses of LEO 43204 Once Daily for Two Consecutive Days on Full Balding Scalp in Subjects With Actinic Keratosis

Actinic Keratosis

United States
LEO Pharma

Completed

Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Balding Scalp Including 12-month Follow-up

Actinic Keratosis

Germany
Korea University
Samsung Medical Center; Asan Medical Center; Chonnam National University Hospital and other collaborators

Completed

Clinical Trial of Ingenol Mebutate Gel 0.015% & 0.05% in Actinic Keratosis

Actinic Keratosis

Korea, Republic of
Teva Pharmaceuticals USA

Completed

A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Multicenter Study Comparing Diclofenac Sodium Gel, 3% to Solaraze® Gel, 3% in the Treatment of Actinic Keratosis on the Face or Bald Scalp

Actinic Keratosis

United States
DUSA Pharmaceuticals, Inc.

Completed

Short-incubation Levulan Photodynamic Therapy Versus Vehicle for Face/Scalp Actinic Keratosis (AK)

Actinic Keratosis

United States
LEO Pharma

Completed

A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp

Actinic Keratosis

United States
Spirig Pharma Ltd.

Terminated

Observational Trial Tolerability and Efficacy of Resiquimod Gel in Patients Treated for Actinic Keratosis.

Actinic Keratosis

Switzerland, Germany
LEO Pharma

Completed

Ingenol Mebutate Gel, 0.015% Repeat Use for Multiple Actinic Keratoses on Face and Scalp

Actinic Keratosis

Canada, Germany, Australia, France, United Kingdom
Peplin

Completed

A Multicenter Study to Evaluate the Safety and Efficacy of PEP005 Topical Gel When Used to Treat Actinic Keratoses on the Head (Face or Scalp)

Actinic Keratosis

United States, Australia
University of Sao Paulo
LEO Pharma

Completed

Safety and Tolerability Study of Ingenol Mebutate Compared to 5-FU to Treat Facial Actinic Keratosis

Actinic Keratosis

Brazil
Frankel, Amylynne, M.D.
Graceway Pharmaceuticals, LLC

Unknown

Imiquimod 3.75% Cream in Combination With Cryotherapy in the Treatment of Hypertrophic Actinic Keratoses

Actinic Keratosis

United States
Goldman, Butterwick, Fitzpatrick and Groff
Biofrontera Bioscience GmbH

Not yet recruiting

Comparison of Two Modes of Photodynamic Therapy for the Treatment of Actinic Keratosis on the Upper Extremities

Skin Neoplasms

United States
Case Comprehensive Cancer Center
The Cleveland Clinic; Biofrontera, Inc.

Recruiting

Short Contact Protocols to Reduce Pain During 10% ALA Gel Red-light Photodynamic Therapy of Actinic Keratoses

Actinic Keratosis

United States
PharmaEssentia
PharmaEssentia Japan K.K.

Completed

A Multi-Center Study to Evaluate the Efficacy and Safety of KX01 Ointment 1% on Actinic Keratosis on Face or Scalp

Actinic Keratosis

Japan
Galderma R&D

Completed

Metvix PDT Versus Vehicle PDT With Aktilite CL128 Lamp in Patients With Actinic Keratosis on the Face and Scalp

Actinic Keratosis

United States, Germany
MEDA Pharma GmbH & Co. KG
Accovion GmbH; Siro Clinpharm Germany GmbH (until June 2013)

Completed

Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses (LEIDA 2) (LEIDA 2)

Actinic Keratosis

Austria, Germany
MEDA Pharma GmbH & Co. KG

Completed

Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses (LEIDA)

Actinic Keratosis

Austria, Germany, France
Almirall, S.A.
Athenex, Inc.

Completed

Activity & Safety Study of KX2-391 Ointment in Participants With Actinic Keratosis on the Face or Scalp

Actinic Keratosis

United States
Almirall, S.A.
Athenex, Inc.

Completed

A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on Actinic Keratosis on Face or Scalp (AK004)

Actinic Keratosis

United States
Brigham and Women's Hospital

Withdrawn

Daylight Photodynamic Therapy for the Treatment of Actinic Keratoses in the Northeast United States (DaylightPDT)

Actinic Keratosis | Non-melanoma Skin Cancer
Teva Pharmaceuticals USA

Completed

Study Comparing Imiquimod Cream, 3.75% to Zyclara® (Imiquimod) Cream, 3.75% in the Treatment of Actinic Keratosis

Actinic Keratosis

United States

3

Subscribe